Drug Shortage Report for SANDOZ IRBESARTAN HCT

Last updated on 2020-12-09 History
Report ID 129102
Drug Identification Number 02337428
Brand name SANDOZ IRBESARTAN HCT
Common or Proper name SANDOZ IRBESARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) IRBESARTAN HYDROCHLOROTHIAZIDE
Strength(s) 150MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500 FCT BO
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-11-27
Estimated end date
Actual end date 2020-12-04
Shortage status Resolved
Updated date 2020-12-09
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-12-09 French Compare
v4 2020-12-09 English Compare
v3 2020-11-28 English Compare
v2 2020-11-27 French Compare
v1 2020-11-27 English Compare